Therefore, the author proposed, could rapid normalization of the cardiometabolic system by GLP-1 RAs be the cause rather than a direct adverse effect of the drug? The commentary adds that further biological plausibility should be considered: GLP-1 receptors are known to be expressed throughout the retina, within retinal ganglion cells, and within the central nervous system, the author wrote
Reported user experiences include nausea, digestive discomfort, hot flashes, and dizziness, though these effects have not been evaluated in controlled studies
Insulin resistance is implicated in several potential adverse metabolic changes, including disturbances in insulin and glucose metabolism, which can affect energy supply and blood flow [4]
Dosing Frequency and Duration BPC-157's short plasma half-life of less than 30 minutes might suggest frequent dosing requirements
Participants first lost weight during a 36-week lead-in period on tirzepatide, then were randomized to either continue the medication or switch to placebo for an additional 52 weeks